scispace - formally typeset
E

Elena Percivalle

Researcher at University of Pavia

Publications -  198
Citations -  9793

Elena Percivalle is an academic researcher from University of Pavia. The author has contributed to research in topics: Human cytomegalovirus & Virus. The author has an hindex of 51, co-authored 176 publications receiving 8400 citations. Previous affiliations of Elena Percivalle include University of Milan & Mario Negri Institute for Pharmacological Research.

Papers
More filters
Journal ArticleDOI

Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes

TL;DR: It is shown here that the UL131-128 gene locus of HCMV is indispensable for both productive infection of endothelial cells and transmission to leukocytes, and suggests that a common mechanism of virus transfer may be involved in both endothelial cell tropism and leukocyte transfer.
Journal ArticleDOI

Monitoring of Human Cytomegalovirus Infections and Ganciclovir Treatment in Heart Transplant Recipients by Determination of Viremia, Antigenemia, and DNAemia

TL;DR: Follow-up of HCMV infections in heart transplant recipients showed that PCR can detect viral appearance in blood 7-10 days earlier than assays for antigenemia/viremia, and viral disappearance from blood, as assessed by PCR, occurred weeks or months later than revealed by other assays.
Journal ArticleDOI

Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.

TL;DR: Comparison of the staining capabilities of three MAbs to pp65 with a commercially available MAb for determination of HCMV antigenemia showed that, while individual MAbs did not provide better results, the pool of MAbs detected a significantly higher number of positive peripheral blood polymorphonuclear leukocytes than Clonab CMV did.
Journal ArticleDOI

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

TL;DR: A human monoclonal antibody (MPE8) that potently cross-neutralizes HRSV and HMPV as well as two animal paramyxoviruses and shows potent prophylactic and therapeutic efficacy and identifies the pre-fusion F protein as a candidate H RSV vaccine.